Q-1802OxaliplatinXELOXcapecitabinePeking University Cancer Hospitaladvanced GC/GEJ
…. Patients with untreated advanced GC/GEJ are administered with Q-1802 (IV, Q2W) respectively at 10 mg/kg and 20 mg/kg dose level in c…
1articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Q-1802 ×
Q-1802
This drug is selected. Its supporting articles are shown below.